| # |
Name |
Date |
| 1 |
201621010159-FORM 2-20-03-2017.pdf |
2017-03-20 |
| 2 |
201621010159-FORM 2 (TITLE PAGE)-20-03-2017.pdf |
2017-03-20 |
| 3 |
201621010159-DESCRIPTION(COMPLETE)-20-03-2017.pdf |
2017-03-20 |
| 4 |
201621010159-CLAIMS-20-03-2017.pdf |
2017-03-20 |
| 5 |
201621010159-ABSTRACT-20-03-2017.pdf |
2017-03-20 |
| 6 |
201621010159-FORM 5-27-03-2017.pdf |
2017-03-27 |
| 7 |
Albendazole complete specification 201621010159.pdf |
2018-08-11 |
| 8 |
201621010159-Form 3-230316.pdf |
2018-08-11 |
| 9 |
201621010159-Form 2(Title Page)-230316.pdf |
2018-08-11 |
| 10 |
201621010159-Form 1-230316.pdf |
2018-08-11 |
| 11 |
201621010159-PRE GRANT OPPOSITION FORM [01-06-2020(online)].pdf |
2020-06-01 |
| 12 |
201621010159-Form 18-200320.pdf |
2020-06-11 |
| 13 |
201621010159-Correspondence-200320.pdf |
2020-06-11 |
| 14 |
201621010159-FORM-26 [23-04-2021(online)].pdf |
2021-04-23 |
| 15 |
201621010159-FER.pdf |
2021-10-18 |
| 16 |
201621010159-Power of Attorney-261121.pdf |
2021-11-30 |
| 17 |
201621010159-Form 2(Title Page)-261121.pdf |
2021-11-30 |
| 18 |
201621010159-Examination Report Reply Recieved-261121.pdf |
2021-11-30 |
| 19 |
201621010159-Amended Pages Of Specification-261121.pdf |
2021-11-30 |
| 20 |
201621010159-Abstract-261121.pdf |
2021-11-30 |
| 21 |
201621010159-PreGrant-HearingNotice-(HearingDate-24-01-2024).pdf |
2023-12-26 |
| 22 |
201621010159-FORM 30 & 26-261223.pdf |
2023-12-27 |
| 23 |
201621010159-Correspondence to notify the Controller [23-01-2024(online)].pdf |
2024-01-23 |
| 24 |
201621010159-Written submissions and relevant documents [07-02-2024(online)].pdf |
2024-02-07 |
| 25 |
201621010159-REPLY TO HEARING-080224.pdf |
2024-02-09 |
| 26 |
201621010159-Power of Attorney-080224.pdf |
2024-02-09 |
| 27 |
201621010159-MARKED COPY-080224.pdf |
2024-02-09 |
| 28 |
201621010159-Claims-080224.pdf |
2024-02-09 |
| 29 |
201621010159-PatentCertificate29-02-2024.pdf |
2024-02-29 |
| 30 |
201621010159-IntimationOfGrant29-02-2024.pdf |
2024-02-29 |